Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
ONCY
2 quarters
Position history for JPMorgan Chase & Co.'s holdings in Oncolytics Biotech Inc.
Yes. JPMorgan Chase holds 163 shares of ONCY (Oncolytics Biotech), worth $157, as of its Q2 2026 13F filing. It reduced the position by 1,114 shares (-87.2%) from Q1 2026. JPMorgan Chase has held ONCY since Q1 2026, across 2 quarterly 13F filings.
Current Value
$157
Current Shares
163
Total Value Change
-$871
Total Shares Change
-1,114
Quarter-by-Quarter History
Other major holders of ONCY: Marshall Wace, LLP, Renaissance Technologies LLC, Morgan Stanley, Citadel Advisors LLC